Quantum Technologies Strategic Imperatives for Health and Healthcare Leaders 2025

Commercial examples TABLE 2 Use case examples End user Ecosystem partner Quantum photonic particle sensing for inline bioprocess controlFesto LifeTech Division Q.ANT NV-diamond biosensing for nanoparticle/biomarker assaysHarvard University and Boston Area Hospitals Quantum Diamond Technologies (QDTI) Stage 2: Prototype readiness (3–5 years) The largest group of use cases sits here. The following is a non-exhaustive list of quantum use cases as they are being explored by large pharma R&D labs to demonstrate their feasibility and advantage when compared to classical systems. These use cases already have enterprise prototypes and academic validation in place, and data assets exist to test their performance against classical baselines. They represent the frontier for near-term competitive advantage; early movers can shape intellectual property (IP), attract scarce quantum talent and build proprietary workflows.Actionable items to enable prototype readiness –Launch targeted pilots in collaboration with pharma companies, contract research organizations (CROs) or hospitals. –Define clear key performance indicators (KPIs) (e.g. solution diversity, time-to-insight, attrition delta). –Engage regulators early to align validation standards. First-mover advantage: Accelerate development timelines, reduce attrition and establish stronger drug pipelines. Prototype examples TABLE 3 Use case examples End user Ecosystem partner mRNA secondary structure prediction Moderna IBM Molecular dynamics simulation Qubit Pharmaceuticals PASQAL, NVIDIA High-throughput ligand-protein interaction simulationQubit Pharmaceuticals PASQAL Bio-silico peptide screening for biomolecules and biomarkersSão Paulo State University (UNESP) Qnity Cohort selection optimization Cleveland Clinic IBM Quantum Technologies: Strategic Imperatives for Health and Healthcare Leaders 11